Covidien Unit Escapes FCA Suit Over Off-Label Marketing
A Massachusetts federal judge on Tuesday tossed a whistleblower's suit accusing a Covidien Ltd. subsidiary of, among other things, promoting off-label uses for its blood-blockage device, saying the suit was precluded...To view the full article, register now.
Already a subscriber? Click here to view full article